APO RESEARCH · REPORT
Acne Medicine
The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, dapsone. The most common oral medications for acne are antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.
Product & engineering
Understand the product.
The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, dapsone. The most common oral medications for acne are antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.
Selected research
Industry Research
Acne Medicine Industry Research Report 2026
Market perspective
The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, dapsone. The most common oral medications for acne are antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.
By type，in 2020, Prescription Medicine accounted for a share of 78% in the global Acne Medicine market. In Acne Medicine market, the Topical holds an important share in terms of Application about74.17%.
Report Scope
Read the full market overview
This report quantifies the global Acne Medicine market in terms of revenue (US$ million) and, where applicable, service volume (units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Acne Medicine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Acne Medicine Market by Company
Galderma
Bausch Health
Teva
GlaxoSmithKline
Mylan
Almirall
Sun Pharma
Mayne Pharma
Lion
HUAPONT
Sine Pharma
Acne Medicine Segment by Type
OTC
Prescription Medicine
Acne Medicine Segment by Application
Topical
Oral
Acne Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acne Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acne Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acne Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Acne Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- OTC
- Prescription Medicine
Applications
- Topical
- Oral
Companies covered
- Galderma
- Bausch Health
- Teva
- GlaxoSmithKline
- Mylan
- Almirall
- Sun Pharma
- Mayne Pharma
- Lion
- HUAPONT
- Sine Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Acne Medicine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 OTC
- 2.2.3 Prescription Medicine
- 2.3 Acne Medicine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Topical
- 2.3.3 Oral
- 2.4 Assumptions and Limitations
3 Acne Medicine Breakdown Data by Type
- 3.1 Global Acne Medicine Historic Market Size by Type (2021-2026)
- 3.2 Global Acne Medicine Forecasted Market Size by Type (2027-2032)
4 Acne Medicine Breakdown Data by Application
- 4.1 Global Acne Medicine Historic Market Size by Application (2021-2026)
- 4.2 Global Acne Medicine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Acne Medicine Market Perspective (2021-2032)
- 5.2 Global Acne Medicine Growth Trends by Region
- 5.2.1 Global Acne Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Acne Medicine Historic Market Size by Region (2021-2026)
- 5.2.3 Acne Medicine Forecasted Market Size by Region (2027-2032)
- 5.3 Acne Medicine Market Dynamics
- 5.3.1 Acne Medicine Industry Trends
- 5.3.2 Acne Medicine Market Drivers
- 5.3.3 Acne Medicine Market Challenges
- 5.3.4 Acne Medicine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Acne Medicine Players by Revenue
- 6.1.1 Global Top Acne Medicine Players by Revenue (2021-2026)
- 6.1.2 Global Acne Medicine Revenue Market Share by Players (2021-2026)
- 6.2 Global Acne Medicine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Acne Medicine Head Office and Area Served
- 6.4 Global Acne Medicine Players, Product Type & Application
- 6.5 Global Acne Medicine Manufacturers Established Date
- 6.6 Global Acne Medicine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Acne Medicine Market Size (2021-2032)
- 7.2 North America Acne Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Acne Medicine Market Size by Country (2021-2026)
- 7.4 North America Acne Medicine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Acne Medicine Market Size (2021-2032)
- 8.2 Europe Acne Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Acne Medicine Market Size by Country (2021-2026)
- 8.4 Europe Acne Medicine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Acne Medicine Market Size (2021-2032)
- 9.2 Asia-Pacific Acne Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Acne Medicine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Acne Medicine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Acne Medicine Market Size (2021-2032)
- 10.2 South America Acne Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Acne Medicine Market Size by Country (2021-2026)
- 10.4 South America Acne Medicine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Acne Medicine Market Size (2021-2032)
- 11.2 Middle East & Africa Acne Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Acne Medicine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Acne Medicine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Galderma
- 12.1.1 Galderma Company Information
- 12.1.2 Galderma Business Overview
- 12.1.3 Galderma Revenue in Acne Medicine Business (2021-2026)
- 12.1.4 Galderma Acne Medicine Product Portfolio
- 12.1.5 Galderma Recent Developments
- 12.2 Bausch Health
- 12.2.1 Bausch Health Company Information
- 12.2.2 Bausch Health Business Overview
- 12.2.3 Bausch Health Revenue in Acne Medicine Business (2021-2026)
- 12.2.4 Bausch Health Acne Medicine Product Portfolio
- 12.2.5 Bausch Health Recent Developments
- 12.3 Teva
- 12.3.1 Teva Company Information
- 12.3.2 Teva Business Overview
- 12.3.3 Teva Revenue in Acne Medicine Business (2021-2026)
- 12.3.4 Teva Acne Medicine Product Portfolio
- 12.3.5 Teva Recent Developments
- 12.4 GlaxoSmithKline
- 12.4.1 GlaxoSmithKline Company Information
- 12.4.2 GlaxoSmithKline Business Overview
- 12.4.3 GlaxoSmithKline Revenue in Acne Medicine Business (2021-2026)
- 12.4.4 GlaxoSmithKline Acne Medicine Product Portfolio
- 12.4.5 GlaxoSmithKline Recent Developments
- 12.5 Mylan
- 12.5.1 Mylan Company Information
- 12.5.2 Mylan Business Overview
- 12.5.3 Mylan Revenue in Acne Medicine Business (2021-2026)
- 12.5.4 Mylan Acne Medicine Product Portfolio
- 12.5.5 Mylan Recent Developments
- 12.6 Almirall
- 12.6.1 Almirall Company Information
- 12.6.2 Almirall Business Overview
- 12.6.3 Almirall Revenue in Acne Medicine Business (2021-2026)
- 12.6.4 Almirall Acne Medicine Product Portfolio
- 12.6.5 Almirall Recent Developments
- 12.7 Sun Pharma
- 12.7.1 Sun Pharma Company Information
- 12.7.2 Sun Pharma Business Overview
- 12.7.3 Sun Pharma Revenue in Acne Medicine Business (2021-2026)
- 12.7.4 Sun Pharma Acne Medicine Product Portfolio
- 12.7.5 Sun Pharma Recent Developments
- 12.8 Mayne Pharma
- 12.8.1 Mayne Pharma Company Information
- 12.8.2 Mayne Pharma Business Overview
- 12.8.3 Mayne Pharma Revenue in Acne Medicine Business (2021-2026)
- 12.8.4 Mayne Pharma Acne Medicine Product Portfolio
- 12.8.5 Mayne Pharma Recent Developments
- 12.9 Lion
- 12.9.1 Lion Company Information
- 12.9.2 Lion Business Overview
- 12.9.3 Lion Revenue in Acne Medicine Business (2021-2026)
- 12.9.4 Lion Acne Medicine Product Portfolio
- 12.9.5 Lion Recent Developments
- 12.10 HUAPONT
- 12.10.1 HUAPONT Company Information
- 12.10.2 HUAPONT Business Overview
- 12.10.3 HUAPONT Revenue in Acne Medicine Business (2021-2026)
- 12.10.4 HUAPONT Acne Medicine Product Portfolio
- 12.10.5 HUAPONT Recent Developments
- 12.11 Sine Pharma
- 12.11.1 Sine Pharma Company Information
- 12.11.2 Sine Pharma Business Overview
- 12.11.3 Sine Pharma Revenue in Acne Medicine Business (2021-2026)
- 12.11.4 Sine Pharma Acne Medicine Product Portfolio
- 12.11.5 Sine Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst